DermatOstéo: Association Between Dermatoporosis and Fractural Risk

Sponsor
Fondation Ophtalmologique Adolphe de Rothschild (Other)
Overall Status
Completed
CT.gov ID
NCT03998228
Collaborator
(none)
100
1
4
24.7

Study Details

Study Description

Brief Summary

There is a need for new tools to identify patients who may have osteoporosis before a fracture occurs.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Dual X-ray absorptiometry (DMO) densitometry.

Study Design

Study Type:
Observational
Actual Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Association Between Dermatoporosis and Fractural Risk
Actual Study Start Date :
Oct 1, 2020
Actual Primary Completion Date :
Feb 1, 2021
Actual Study Completion Date :
Feb 1, 2021

Outcome Measures

Primary Outcome Measures

  1. compare fracture risk between patients with dermatoporosis and those without dermatoporosis [BASELINE]

    The fracture risk will be calculated using the FRAX score. The presence of dermatoporosis will be assessed by a simple clinical examination of the forearms and defined by the presence of three clinical signs: cutaneous atrophy, Bateman purpura and presence of pseudo-stellar scars.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient aged between 40 and 90 years old who has to undergo a bone densitometry (BMD) examination by dual X-ray absorptiometry

  • Affiliate or beneficiary of a Social Security scheme

  • Express consent to participate in the study.

Exclusion Criteria:
  • Patient benefiting from a legal protection measure

  • Pregnant or nursing woman.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Fondation Adolphe de Rothschild Paris France 75019

Sponsors and Collaborators

  • Fondation Ophtalmologique Adolphe de Rothschild

Investigators

  • Principal Investigator: Thomas SENE, MD PhD, Hôpital Fondation Adolphe de Rothschild

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fondation Ophtalmologique Adolphe de Rothschild
ClinicalTrials.gov Identifier:
NCT03998228
Other Study ID Numbers:
  • TSE_2019_11
First Posted:
Jun 26, 2019
Last Update Posted:
Jul 19, 2021
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jul 19, 2021